Global Anticoccidial Drugs Market in Animal Health - Trends and Forecasts (2017 - 2022)
|出版商||Mordor Intelligence LLP||商品編碼||319306|
|出版日期||內容資訊||英文 193 Pages
|全球動物醫療的抗球蟲藥市場:全球的趨勢與預測 Global Anticoccidial Drugs Market in Animal Health - Trends and Forecasts (2017 - 2022)|
|出版日期: 2017年01月24日||內容資訊: 英文 193 Pages||
The global anticoccidial drugs market in animal health is expected to reach USD 24.33 billion by the year 2020.
Global Anticoccidial Drugs Market in Animal Health- Market Dynamics
In the veterinary antibiotic market, the market for food producing animals accounted for nearly 80% of the total market in 2011. This has increased the demand for anticoccidial drugs, largely due to the increased incidence of coccidiosis and other protozoan parasite based diseases that infect majorly food producing organisms but are not limited to them. In the poultry and cattle markets, the incidence of coccidiosis has cost millions of dollars in treatment and preventive care. Also, the trend of owning companion animals is also contributing to the increasing use of anticoccidials, as dogs, cats and occasionally even horses are prone to coccidiosis and if left untreated, it could lead to the death of the animal.
Some of the other factors driving this market are:
Increase in global population
Increase in the per capita global consumption of meat
Increased adoption of intensive farming methods
The global anticoccidial market has been segmented on the basis of animal type (poultry, cattle, swine, and companion animals), drugs (ionophore anticoccidials, chemical derivative anticoccidials, and antibiotic anticoccidials), and by geography (North America, Europe, Asia-Pacific and Rest of the World).
The Asia-Pacific region is set to be the largest contributor in terms of total revenue in this market by the year 2020. The countries set to be major contributors in this region are China, India, Japan, and Australia. The growth in the North American and European markets is set to be stagnant due to the stagnated market and government restrictions.
Some of the key players in the market are:
Bayer Healthcare Animal Healthcare Division
Elanco (A division of Eli Lilly and Company)
Merck Animal Healthcare
What the Report Offers
Market definition for the specified topic along with identification of key drivers and restraints for the market.
Market analysis for the anticoccidial drugs market in the healthcare industry, with region specific assessments and competition analysis on a global and regional scale.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.
Identification and analysis of the macro and micro factors that affect the anticoccidial drugs market in the healthcare industry on both global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
7. Region-wise analysis of anticoccidial market (Market size, Forecast, and CAGR)
8. Segmentation by Animal Type - anticoccidial market (Market size, Forecast, and CAGR)
9 The future of anticoccidial market 10 Competitive Landscape
11 Company Profiles